NEW YORK (GenomeWeb News) – Medical imaging and diagnostics products firm Hologic said today that it will acquire Third Wave Technologies for $11.25 per share, or approximately $580 million.
The acquisition will provide Hologic with complementary products targeted to the women’s health and diagnostics market. The Bedford, Mass.-based firm sells the ThinPrep pap test, while Madison, Wis.-based Third Wave recently filed for US Food and Drug Administration clearance for two molecular diagnostic tests for human papillomavirus.